HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stada's Nature's Aid Launches Sustainable Supplements In UK, Frustrated At CBD Delays

Executive Summary

HBW Insight catches up with Nature's Aid managing director Chris Morrey to talk about the firm's new sustainable dietary supplment range, Wild Earth, as well as the challenges posed by the UK's new regulstory regime for CBD novel foods. 

You may also be interested in...



Skin Care And VMS Propel Growth At Stada’s UK Business

Strong dermatology sales at Stada's UK Thornton & Ross subsidiary offset an almost non-existent cough and cold season, helping the business deliver almost double-digit growth in 2020, according to executive vice-president Roger Scarlett-Smith. 

‘Acquisitive and Entrepreneurial’ Stada Spies Further M&A Opportunities In US And Elsewhere

Stada Arzneimittel is looking for local partners and/or acquisition opportunities in the US to expand its offer and quickly establish its presence in the country, Stada executive vice president Roger Scarlett-Smith tells HBW Insight in this exclusive interview.

‘Open For Business’ – R&D Partnerships Key To Stada’s Ambitious Growth Strategy

R&D partnerships are key to Stada's ambitious growth strategy, the company's new CHC innovation chief, Steve Makin tells HBW Insight, in the second part of an exclusive interview. CBD and probiotics are particularly exciting areas within the post-COVID wellness/prevention mega-trend, he says, in which Stada is already making headway with new products. 

Related Content

Topics

UsernamePublicRestriction

Register

RS152017

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel